Dorta RE, Tablada RRJ, Arias JAC

Language: Spanish
References: 19
Page: 1-13
PDF size: 254.00 Kb.

ABSTRACT

It was performed a case and witness study in patients with acute myocardial infarction with hypertension diagnosis in the Medical Center of Integral Diagnosis ¨Secundino Urbina¨ from the municipality of Coro, Falcon State, in the Bolivarian Republic of Venezuela, during the period of January 1st, 2008 to December 31st of 2010, with the objective to identify the influence of specific risk factors in the presence of this disease. The sample was obtained at random and it was integrated by 70 cases and 70 witnesses. In the unvaried analysis most of the researched factors constituted a risk for the presence of the acute myocardial infarction. The multivariate analysis showed that the most important factor with independent influence was the level of severity; grade IV OR: 6.23; IC: 4, 12-10, 56; p: 0.000), followed by the evolution time of hypertension (OR: 4.57; IC: 2.54-7.89; p: 0.000) and the age over than 65 years, (OR: 3, 25; IC: 2, 48-8, 96; p: 0,001). It was concluded that with the obtained values in the model of logistic regression for the risk factors of independent influence in the presence of the acute myocardial infarction in hypertensive patients, it is offered an approximate idea of the probability to increase the aforesaid disease.

REFERENCES

1. Elliot M. animan, Eugene Braunwald. Infarto Agudo de Miocardio. En: Harrison. Principios de Medicina Interna. 15а edición. Madrid. McGraw-Hill Interamericana de España; 2006. p.1629.

2. Macías Guarasa I. Tesis doctoral pronóstico y estancia media de los pacientes con angina inestable durante su ingreso en las unidades de cuidados intensivos o unidades coronarias españolas. Disponible en: http://hera.ugr.es/tesisugr/15888794.pdf (consultado 12 de mayo 2010).

3. Farreras, Rozman. Medicina Interna. 14a edición. Sección 3.Trastornos Cardiovasculares. Madrid: Salvat ediciones España; 2005.

4. Delcán JL. Cardiopatía Isquémica. Epidemiología de la Cardiopatía Isquémica: Factores de Riesgo y Prevención Primaria. Madrid: Salvat ediciones; 2006.

5. De Backer G, Ambrosioni E, Borch-Johnsem K, Brotons C, Cifkova R, Dallongaville J, et al. Third Joins Task Force of European and other Societies on Cardiovascular Diseases Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Eur J Cardio Prev Rev. 2009; 10 supl 1:1-78.

6. Velázquez-Monroy O, Rosas Peralta M, Lara Esqueda A, Pastelín Hernández G, Castillo C, Attie F, et al. Prevalencia e interrelación de enfermedades crónicas no transmisibles y factores de riesgo cardiovascular en México: resultados finales de la Encuesta Nacional de Salud (ENSA) 2000. Arch Cardiol Mex. 2008; 73: 62-77.

7. Avezum Á, Braga J, Santos Í, Guimarães HP, Marin-Neto JA, Piegas LS. Cardiovascular disease in South America: current status and opportunities for prevention. Heart. 2009; 95; 1475-82. VERSION ON-LINE: ISSN 1028-4818 Multimed. Revista Médica. Granma RPNS-1853 12

8. Bertomeu V, Quiles J. La hipertensión en atención primaria: ¿conocemos la magnitud del problema y actuamos en consecuencia? Rev Esp Cardiol. 2010; 58: 338 – 40.

9. Vega G, Martínez S, A Jiménez P, Navarro A, Bernad F. Efecto de los factores de riesgo cardiovascular sobre la morbimortalidad a largo plazo después de un infarto agudo de miocardio. Rev Esp Cardiol. 2009; 60: 703

10. Kliver M, Berman S, Muntaner J, Herrera R, Luciardi H. Epidemiología y factores de riesgo. Disponible en: www.sac.org.ar/rac/2003/v4_b/cg-1.pdf (consultado el 24 de enero de 2010).

11. Blumel MJE, Prieto DJC, Leal IT. Impacto de los factores de riesgo coronario en mujeres de edad media. Rev. Méd Chile. 2008;1129 (9):995-02.

12. Cordero A, Moreno J, Alegría E. Hipertensión arterial y síndrome metabólico. Rev Esp Cardiol. 2011; 5: 38 – 45.

13. The Seventh Report of the Joint National Comitte on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. JAMA. 2009;289(19):2560-71.

14. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burniere M, Caulfieldf MJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009, 27(11):2121–58.

15. Tousoulis D, Koumallos N, Antoniades C, Antonopoulos AS, Bakogiannis B, Milliou A, et al. Genetic polymorphism on type 2 receptor of angiotensin II, modifies cardiovascular risk and systemic inflammation in hypertensive males. Am J Hypertens. 2010;23:237-242.

16. García Barreto D, Álvarez González J, García Fernández R, Valiente Mustelier IJ, Hernández Cañero A. La hipertensión arterial en la tercera edad. Rev Cubana Med. 2009; 48(2).

17. Díez J, Frohlich ED. A translational approach to hypertensive heart disease. Hypertension. 2010;55:1-8. VERSION ON-LINE: ISSN 1028-4818 Multimed. Revista Médica. Granma RPNS-1853 13

18. Sierra C, de la Sierra A. Early detection and management of the high-risk patient with elevated blood pressure. Vasc Health Risk Manag. 2008:4(2) 289–296.

19. Alfonso Guerra JP. Daño en órganos relacionados con la hipertensión arterial. Factores de riesgo modificables. En: Alfonso Guerra JP, Pérez Caballero MD, Hernández Cueto MJ, García Barreto D, editores. Hipertensión arterial en la atención primaria de salud. La Habana: Editorial Ciencias Médicas; 2009. p. 129-139.